Sabinsa announced the publication of a preliminary study evaluating the safety, tolerability, and health benefits of Sabeet, a standardized beetroot extract, in older adults.
The study demonstrated that the ingredient was safe and well-tolerated as a daily supplement over a period of 12 weeks, in 12 participants who were ages 60 and up.
During the study, no serious adverse events were reported, and researchers reported a notable increase in plasma nitrate levels, as well as that participants trended toward markers of improved insulin sensitivity.
“This preliminary study was conducted to underscore the safety and tolerability of Sabeet, but we are pleased to see the benefits it indicated as well,” said Shaheen Majeed, global CEO and managing director of the Sami-Sabinsa Group. “These findings align with our commitment to providing scientifically backed, safe, and effective dietary supplements. Sabinsa extends its gratitude to the team in Food and Nutrition Institute at Federal University of Rio de Janeiro for their collaboration in this study, and we look forward to continuing collaboration.”
